Effect of Psychoeducation on Internalized Stigma and Anxiety in Patients Receiving Electroconvulsive Therapy (PE-ECT)
THE EFFECT OF PSYCHOEDUCATION PROGRAM APPLIED TO PATIENTS RECEIVING ELECTROCONVULSIVE THERAPY ON PATIENTS' INTERNALIZED STIGMA AND ANXIETY LEVELS: A RANDOMIZED CONTROLLED STUDY
This randomized controlled clinical trial was conducted to evaluate the effect of a psychoeducational programme on internalised stigma and anxiety levels in patients undergoing electroconvulsive therapy (ECT). The study aimed to determine whether the psychoeducational intervention reduces internalised stigma related to mental illness and improves anxiety outcomes compared to routine nursing care.
The primary questions addressed were:
Does the psychoeducational programme reduce internalised stigma in patients receiving ECT? Does the intervention decrease state and trait anxiety levels compared to routine care? Researchers compared a psychoeducational intervention group with a control group receiving routine nursing care to assess the effects of the programme on psychological outcomes.
Participants in the intervention group:
Received a six-session psychoeducational programme delivered individually over six weeks Completed pre-test and post-test assessments using standardized measurement tools
Participants in the control group received routine psychiatric nursing care and completed the same assessment measures at equivalent time points.
Descripción general del estudio
Estado
Condiciones
Intervención / Tratamiento
Tipo de estudio
Inscripción (Actual)
Fase
- No aplica
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
Meram
-
Konya, Meram, Turquía (Türkiye)
- Necmettin Erbakan University
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
- Adulto
- Adulto Mayor
Acepta Voluntarios Saludables
Descripción
Inclusion Criteria:
- Age ≥ 18 years
- Able to read and write in Turkish
- At least primary school graduate
- Diagnosed according to DSM-5 criteria with schizophrenia or other psychotic disorders, bipolar disorder, major depressive disorder, obsessive-compulsive disorder, or generalized anxiety disorder
- Inpatients in a psychiatric clinic
- Receiving or scheduled to receive electroconvulsive therapy (ECT)
- No severe agitation or homicidal risk as determined by the treating psychiatrist
- Voluntary consent to participate in the study
Exclusion Criteria:
- Diagnosis of organic mental disorders (e.g., dementia, Alzheimer's disease, delirium)
- Intellectual disability
- History of alcohol or substance dependence
- Not completing at least 4 ECT sessions during the treatment process
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Investigación de servicios de salud
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Único
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
|---|---|
|
Experimental: Psychoeducation Group (Arm 1)
Participants received a structured psychoeducational programme in addition to routine psychiatric care.
|
A structured psychoeducational programme consisting of six individual face-to-face sessions delivered over six weeks by the researcher.
The programme aimed to reduce internalised stigma and anxiety in patients undergoing electroconvulsive therapy (ECT) and included education about illness, treatment process, coping strategies, and emotional support.
|
|
Comparador activo: Routine Care Group (Arm 2)
Participants in this arm received routine psychiatric nursing care provided in the inpatient psychiatric clinic without any additional psychoeducational intervention.
|
Standard psychiatric nursing care provided during electroconvulsive therapy (ECT) treatment.
No structured psychoeducational programme was applied.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
Internalised Stigma Scale for Mental Illness (ISMI)
Periodo de tiempo: Baseline and 6 weeks post-intervention
|
Change in internalized stigma levels in patients undergoing electroconvulsive therapy (ECT), measured using the Internalized Stigma of Mental Illness Scale (ISMI).
Higher scores indicate higher levels of internalized stigma.
|
Baseline and 6 weeks post-intervention
|
Medidas de resultado secundarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
State Anxiety Score (STAI-State)
Periodo de tiempo: Baseline and 6 weeks post-intervention
|
Change in state anxiety levels in patients undergoing electroconvulsive therapy (ECT), measured using the STAI-State subscale.
Higher scores indicate higher levels of current anxiety.
|
Baseline and 6 weeks post-intervention
|
|
Trait Anxiety Score (STAI-Trait)
Periodo de tiempo: Baseline and 6 weeks post-intervention
|
Change in trait anxiety levels in patients undergoing electroconvulsive therapy (ECT), measured using the STAI-Trait subscale.
Higher scores indicate general anxiety tendency.
|
Baseline and 6 weeks post-intervention
|
Colaboradores e Investigadores
Patrocinador
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- NEU-PhDHEM-2026-01
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .